Burden of end-stage renal disease in sub-Saharan Africa

2011 ◽  
Author(s):  
S. Naicker
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Sub Saharan Africa ◽  
Sub Saharan ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Pilot Experience in Senegal with Peritoneal Dialysis for End-Stage Renal Disease

2014 ◽  
Vol 34 (5) ◽  
pp. 539-543 ◽  
Author(s):  
Abdou Niang ◽  
Mouhamadou Moustapha Cisse ◽  
Sidi Mohamed Ould M. Mahmoud ◽  
Ahmed Tall Ould Lemrabott ◽  
El Hadji Fary Ka ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Renal Disease ◽  
Health Care Providers ◽  
End Stage Renal Disease ◽  
Sub Saharan Africa ◽  
Care Providers ◽  
Female Ratio ◽  
Sub Saharan ◽  
Stage Renal Disease ◽  
End Stage

IntroductionPeritoneal dialysis (PD) is occasionally used in western sub-Saharan Africa to treat patients with end-stage renal disease (ESRD). The present study is a retrospective review of the initial six years’ experience with PD for ESRD therapy in Senegal, a West African country with a population of over 12 million.Material and MethodsSingle-center retrospective cohort study of patients treated with PD between March 2004 and December 2010. Basic demographic data were collected on all patients. Peritonitis rates, causes of death and reasons for transfer to hemodialysis (HD) were determined in all patients.ResultsSixty-two patients were included in the study. The median age was 47 ± 13 years with a male/female ratio of 1.21. Nephrosclerosis and diabetic nephropathy were the main causes of ESRD. The mean Charlson score was 3 ± 1 with a range of 2 to 7. Forty five peritonitis episodes were diagnosed in 36 patients (58%) for a peritonitis rate of 1 episode/20 patient-months (0.60 episodes per year). Staphylococcus aureus and Pseudomonas aeruginosa were the most commonly identified organisms. Touch contamination has been implicated in 26 cases (57.7%). In 23 episodes (51%), bacterial cultures were negative. Catheter removal was necessary in 12 cases (26.6%) due to mechanical dysfunction, fungal or refractory infection. Sixteen patients died during the study.ConclusionPeritoneal dialysis is a suitable therapy which may be widely used for ESRD treatment in western sub-Saharan Africa. A good peritonitis rate can be achieved despite the difficult living conditions of patients. Challenges to the development of PD programs include training health care providers, developing an infrastructure to support the program, and developing a cost structure which permits expansion of the PD program.

Burden of end-stage renal disease in sub-Saharan Africa

2020 ◽  
Vol 93 (1) ◽  
pp. 3-7 ◽  
Author(s):  
Fatiu A. Arogundade ◽  
Bolanle A. Omotoso ◽  
Adegbola Adelakun ◽  
Titilope Bamikefa ◽  
Remigus Ezeugonwa ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Sub Saharan Africa ◽  
Sub Saharan ◽  
Stage Renal Disease ◽  
End Stage

Acute hemodialysis complications in end-stage renal disease patients: The burden and implications for the under-resourced Sub-Saharan African health systems

2012 ◽  
Vol 16 (4) ◽  
pp. 526-531 ◽  
Author(s):  
Francois Folefack Kaze ◽  
Gloria Ashuntantang ◽  
Andre Pascal Kengne ◽  
Aboubakar Hassan ◽  
Marie Patrice Halle ◽  
...  
Keyword(s):  
Renal Disease ◽  
Health Systems ◽  
End Stage Renal Disease ◽  
African Health ◽  
Sub Saharan ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Massive Bilateral Hydroureteronephrosis and End-Stage Renal Disease Ensuing From Chronic Schistosomiasis: A Case Report

2020 ◽  
Vol 8 ◽  
pp. 232470962091091
Author(s):  
Pedro Pallangyo ◽  
Smita Bhalia ◽  
Nontobeko Nokulunga Simelane ◽  
Frederick Lyimo ◽  
Happiness Judical Swai ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Obstructive Uropathy ◽  
Severe Disease ◽  
Sub Saharan Africa ◽  
African Origin ◽  
Extensive Evaluation ◽  
Life Years ◽  
Stage Renal Disease ◽  
End Stage

Globally, schistosomal infections affect over 200 million people resulting in the loss of 70 million disability-adjusted life years. In the sub-Saharan Africa region, where over 85% of the global schistosomal infections are found, it is estimated that about 120 million people become symptomatic, over 20 million have severe disease, and nearly 200 000 die every year. Renal impairment is a severe consequence of schistosomiasis occurring in about 6% of all infected individuals and in 15% of those with the hepatosplenic form. We present a case of massive bilateral hydroureteronephrosis and end-stage renal disease resulting from chronic schistosomiasis in a 38-year-old male of African origin. A 38-year-old male rice farmer of African origin presented with a history of elevated blood pressure, abdominal swelling, and reduced urinary output for about 10 months. Abdominal examination revealed an intraabdominal mass measuring 30 cm × 17 cm extending from the right hypochrondrium region downward to right inguinal outward to umbilicus crossing the midline. He had an estimated glomerular filtration rate of 3.9 mL/min, hemoglobin of 6.78 g/dL, and had multiple electrolyte abnormalities. A computed tomography intravenous urogram scan of the abdomen revealed hepatomegaly (18 cm), bilateral renal enlargement with hydroureteronephrosis, and multiple calcifications on the urinary bladder. A rectal biopsy isolated haematobium eggs and confirmed the diagnosis. Urinary schistosomiasis can have distressing effects on the urinary system in particular and survival prospects in general. In view of this, extensive evaluation of the genitourinary system is pivotal for timely diagnosis and prompt management particularly in residents of schistosoma-endemic communities presenting with obstructive uropathy.

Sign in / Sign up

Export Citation Format

Share Document